Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-1.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-7.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-11.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-10.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-12.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans alh-9.
Predicted to enable NAD binding activity and oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Is an ortholog of C. elegans C33F10.14.
Predicted to enable oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in aldehyde metabolic process. Is an ortholog of C. elegans alh-4.
Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin-like, C-terminal; Arrestin (or S-antigen), C-terminal domain; Arrestin C-terminal-like domain; and Immunoglobulin E-set.
Is predicted to encode a protein with the following domains: Arrestin (or S-antigen), N-terminal domain; Arrestin-like, N-terminal; Arrestin-like, C-terminal; Arrestin (or S-antigen), C-terminal domain; Arrestin C-terminal-like domain; and Immunoglobulin E-set.